Exchange: NASDAQ·Updated 08:28 AM EDT
IMRN logo

IMRN IMMURON Ltd/S ADR

$1.22
$0.00
(0.00%)
Pre-Market
Prev Close $1.22
Mkt Cap$9.85M
Vol2,667.00

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.
41

Bearish Sentiment

How do you feel about IMRN?

Advertisement|Remove ads.